227 related articles for article (PubMed ID: 10490037)
1. Cyclic vomiting syndrome: timing, targets, and treatment--a basic science perspective.
Andrews PL
Dig Dis Sci; 1999 Aug; 44(8 Suppl):31S-38S. PubMed ID: 10490037
[TBL] [Abstract][Full Text] [Related]
2. Central mechanisms of vomiting.
Miller AD
Dig Dis Sci; 1999 Aug; 44(8 Suppl):39S-43S. PubMed ID: 10490038
[TBL] [Abstract][Full Text] [Related]
3. Noxious stimulation of emesis.
Lang IM
Dig Dis Sci; 1999 Aug; 44(8 Suppl):58S-63S. PubMed ID: 10490041
[TBL] [Abstract][Full Text] [Related]
4. Cyclic vomiting syndrome: features to be explained by a pathophysiologic model.
Li BU; Fleisher DR
Dig Dis Sci; 1999 Aug; 44(8 Suppl):13S-18S. PubMed ID: 10490033
[TBL] [Abstract][Full Text] [Related]
5. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.
Mahesh R; Perumal RV; Pandi PV
Pharmazie; 2005 Feb; 60(2):83-96. PubMed ID: 15739895
[TBL] [Abstract][Full Text] [Related]
6. The role of neurokinin-1 receptor antagonists for the management of postoperative nausea and vomiting.
Apfel CC; Malhotra A; Leslie JB
Curr Opin Anaesthesiol; 2008 Aug; 21(4):427-32. PubMed ID: 18660647
[TBL] [Abstract][Full Text] [Related]
7. Anti-emetic therapy in cancer chemotherapy: current status.
Herrstedt J; Dombernowsky P
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
[TBL] [Abstract][Full Text] [Related]
8. Disorders of the central and autonomic nervous systems as a cause for emesis in infants.
Johns DW
Semin Pediatr Surg; 1995 Aug; 4(3):152-6. PubMed ID: 7582885
[TBL] [Abstract][Full Text] [Related]
9. Serotonin receptor physiology: relation to emesis.
Hasler WL
Dig Dis Sci; 1999 Aug; 44(8 Suppl):108S-113S. PubMed ID: 10490049
[TBL] [Abstract][Full Text] [Related]
10. Scientific basis of migraine: speculation on the relationship to cyclic vomiting.
Welch KM
Dig Dis Sci; 1999 Aug; 44(8 Suppl):26S-30S. PubMed ID: 10490036
[TBL] [Abstract][Full Text] [Related]
11. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
Herrstedt J
Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.
Jordan K; Kasper C; Schmoll HJ
Eur J Cancer; 2005 Jan; 41(2):199-205. PubMed ID: 15661543
[TBL] [Abstract][Full Text] [Related]
13. Cyclic vomiting syndrome: a disease in disguise.
Bullard J; Page NE
Pediatr Nurs; 2005; 31(1):27-9. PubMed ID: 15794318
[TBL] [Abstract][Full Text] [Related]
14. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
[TBL] [Abstract][Full Text] [Related]
15. Cyclic nausea and vomiting in childhood.
Forbes D; Fairbrother S
Aust Fam Physician; 2008; 37(1-2):33-6. PubMed ID: 18239750
[TBL] [Abstract][Full Text] [Related]
16. Channelopathies: ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system.
Ptácek LJ
Dig Dis Sci; 1999 Aug; 44(8 Suppl):94S-96S. PubMed ID: 10490046
[TBL] [Abstract][Full Text] [Related]
17. Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens.
Trigg ME; Inverso DM
Bone Marrow Transplant; 2008 Oct; 42(8):501-6. PubMed ID: 18724391
[TBL] [Abstract][Full Text] [Related]
18. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
[TBL] [Abstract][Full Text] [Related]
19. Roles of substance P and NK(1) receptor in the brainstem in the development of emesis.
Saito R; Takano Y; Kamiya HO
J Pharmacol Sci; 2003 Feb; 91(2):87-94. PubMed ID: 12686752
[TBL] [Abstract][Full Text] [Related]
20. [New developments in the treatment of nausea and vomiting caused by chemotherapy].
de Wit R; van Alphen MM
Ned Tijdschr Geneeskd; 2003 Apr; 147(15):690-4. PubMed ID: 12722531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
